Jean-Michel Scherrmann, Pharm. D., Ph. D. is Professor in the Department of Pharmacokinetics, Faculty of Pharmacy, the University Paris Descartes. He received his Pharm.D. and Ph. D. in analytical radiochemistry from the University Descartes at Paris. He has led the Neuropsychopharmacology Unit at the French Institute of Health and Medical Research (INSERM) and the National Center of Scientific Research (CNRS) from 2002 to 2013.
He has been recently promoted Dean of the Faculty of Pharmacy at University Paris Descartes and nominated Professor at the National Institute of Nuclear Sciences and Techniques.
Dr. Scherrmann has made significant contributions to the development of drug radioimmunoassay, drug detoxification by immunotherapy and drug redistribution concepts in pharmacokinetics. He pioneered the first clinical application of colchicine immunotherapy in acute colchicine overdoses and is now focusing his research on the role of drug transporters in neuropharmacokinetics and on drug delivery strategies to the brain.
His work has resulted in two patents, 290 scientific articles, 35 books chapters and more than 250 invited presentations. He has served on the editorial boards of several journals in the analytical and pharmaceutical sciences.
He has mentored over 30 postgraduate and 44 doctoral students. Dr. Scherrmann has been a recipient of the 1992 Americal Academy of Clinical Toxicology Award and the 1999 French National Academy of Medicine Achievement Award. He is a Fellow of the American Association of Pharmaceutical Scientists and a member of the French National Academy of Pharmacy. He was visiting Professor at Tohoku University (Japan) Graduate School of Pharmaceutical Sciences in 2008 and awarded as Honoured Member of the French Metabolism and Pharmacokinetics Group in 2014.